Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lois Shepherd

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Breast Cancer Research and Treatment|November 2, 2011
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 TrialKathleen I Pritchard, Alison Munro, Frances P O'Malley, et al.
Haematologica|November 4, 2017
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphomaMark Bosch, Ariz Akhter, Bingshu E Chen, et al.
Clinical Breast Cancer|January 13, 2004
A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trialIvo A Olivotto, Boon Chua, Elizabeth A Elliott, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6Hira Mian, Jolie Ringash, Ralph Meyer, et al.
Biopreservation and Biobanking|August 28, 2014
A practical tool for modeling biospecimen user feesLise Matzke, Simon Dee, John Bartlett, et al.
JAMA Oncology|July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialShuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancerAmy J French, Daniel J Sargent, Lawrence J Burgart, et al.
Oncotarget|September 16, 2015
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsMelanie Spears, Fouad Yousif, Nicola Lyttle, et al.
Clinical Colorectal Cancer|September 2, 2006
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancerMichael J O'Connell, Daniel J Sargent, Harold E Windschitl, et al.
Pediatric Blood & Cancer|September 11, 2009
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129John Gregory, Haesook Kim, Todd Alonzo, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Breast Cancer Research and Treatment|November 2, 2011
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 TrialKathleen I Pritchard, Alison Munro, Frances P O'Malley, et al.
Haematologica|November 4, 2017
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphomaMark Bosch, Ariz Akhter, Bingshu E Chen, et al.
Clinical Breast Cancer|January 13, 2004
A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trialIvo A Olivotto, Boon Chua, Elizabeth A Elliott, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2023
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6Hira Mian, Jolie Ringash, Ralph Meyer, et al.
Biopreservation and Biobanking|August 28, 2014
A practical tool for modeling biospecimen user feesLise Matzke, Simon Dee, John Bartlett, et al.
JAMA Oncology|July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialShuzhen Liu, Bingshu Chen, Samantha Burugu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancerAmy J French, Daniel J Sargent, Lawrence J Burgart, et al.
Oncotarget|September 16, 2015
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trialsMelanie Spears, Fouad Yousif, Nicola Lyttle, et al.
Clinical Colorectal Cancer|September 2, 2006
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancerMichael J O'Connell, Daniel J Sargent, Harold E Windschitl, et al.
Pediatric Blood & Cancer|September 11, 2009
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129John Gregory, Haesook Kim, Todd Alonzo, et al.
Pageof 10